QSAR Modeling and Drug-Likeness Screening for Antioxidant Activity of Benzofuran Derivatives

被引:22
作者
Boudergua, S. [1 ]
Alloui, M. [1 ,2 ]
Belaidi, S. [1 ]
Al Mogren, M. Mogren [3 ]
Ibrahim, U. A. Abd Ellatif [3 ]
Hochlaf, M. [2 ]
机构
[1] Univ Biskra, Fac Sci, Dept Chem, Grp Computat & Pharmaceut Chem,LMCE Lab, Biskra 07000, Algeria
[2] Univ Paris Est, Lab Modelisat & Simulat Multi Echelle, MSME UMR 8208 CNRS, 5 Bd Descartes, F-77454 Marne La Vallee, France
[3] King Saud Univ, Fac Sci, Chem Dept, POB 2455, Riyadh 11451, Saudi Arabia
关键词
Benzofuran derivatives; Antioxidant; QSAR; MLR; ANN; Drug-likeness; HETEROATOM DERIVATIVES; NEURAL-NETWORKS; BENZOXAZOLE; PREDICTION; INHIBITORS; DISCOVERY; RECEPTOR; PYRROLE; INDENE; FURAN;
D O I
10.1016/j.molstruc.2019.04.004
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In order to explore the relationship between the antioxidant activity and structure of fifteen benzofuran derivatives, we carried out a QSAR study using multiple linear regression (MLR) and artificial neural network (ANN) methods. Six descriptors were used as input data (molar weight, surface area, octanol-water partition coefficient, hydration energy, highest occupied molecular orbital energy and lowest unoccupied molecular orbital energy). The electronic properties were derived at the B3LYP/6-31 G (d,p) level. Benchmarks on furan and benzofuran subunits and their comparison to the experiment showed that this level of theory is good enough. The output data correspond to the antioxidant activity as given by IC50. The predicted properties are in agreement with experimental values. Our study shows that 80% of studied molecules are in accordance with the Lipinski and Veber rules and reach the optimal lipophilicity indices. In addition, statistical analysis reveals that ANN technique with (6-2-1) architecture is more significant than MLR model. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:307 / 314
页数:8
相关论文
共 48 条
  • [1] Review on in vivo and in vitro methods evaluation of antioxidant activity
    Alam, Md. Nur
    Bristi, Nusrat Jahan
    Rafiquzzaman, Md.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (02) : 143 - 152
  • [2] Imidazole derivatives as angiotensin II AT1 receptor blockers: Benchmarks, drug-like calculations and quantitative structure-activity relationships modeling
    Alloui, Mebarka
    Belaidi, Salah
    Othmani, Hasna
    Jaidane, Nejm-Eddine
    Hochlaf, Majdi
    [J]. CHEMICAL PHYSICS LETTERS, 2018, 696 : 70 - 78
  • [3] [Anonymous], 2009, JMP 8 0 2
  • [4] [Anonymous], 2008, HYP CHEM MOL MOD SYS
  • [5] [Anonymous], MOLPRO AB INITIO PRO
  • [6] [Anonymous], 2017, MARVINSKETCH17 1 2
  • [7] Arnott J.A., 2013, J. Appl. Biopharm. Pharmacokinet, V1, P31, DOI DOI 10.14205/2309-4435.2013.01.01.6
  • [8] Bahorun T, 2006, INTERNET J MED UPDAT, V1, P25
  • [9] COMPLETE STRUCTURE OF FURAN
    BAK, B
    CHRISTENSEN, D
    HANSENNYGAARD, L
    DIXON, WB
    SCHOTTLANDER, M
    RASTRUPANDERSEN, J
    [J]. JOURNAL OF MOLECULAR SPECTROSCOPY, 1962, 9 (02) : 124 - &
  • [10] Oxidative stress in Alzheimer's disease
    Chen, Zhichun
    Zhong, Chunjiu
    [J]. NEUROSCIENCE BULLETIN, 2014, 30 (02) : 271 - 281